Skip to content

Clinical trials

Phase 3 Heart Defects, Congenital trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Defects, Congenital Phase: Phase 3 Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20042
20064
20091
20102
20121
20132
20141
20152
20161
20173
20181
20202
20211
20221
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting5
Unknown status5
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)3
Mayo Clinic2
Meshalkin Research Institute of Pathology of Circulation2
National Cardiovascular Center Harapan Kita Hospital Indonesia2
Sanofi2
The Hospital for Sick Children2
Actelion1
Asklepion Pharmaceuticals, LLC1
Boston Children's Hospital1
Carelon Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Defects, Congenital35
Cardiovascular Diseases3
Heart Diseases3
Hypertension, Pulmonary3
Hypoplastic Left Heart Syndrome3
Transposition of Great Vessels3
Univentricular Heart3
Euthyroid Sick Syndromes2
Heart Failure2
Heart Septal Defects, Ventricular2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.